Nestle Divests Allergy Treatment Business
Wall Street Journal
Nestle has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer.
Understanding current events through the lenses of the past and future.
Wall Street Journal
Nestle has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer.